Amrize (NYSE:AMRZ) Stock Price Target Lowered at Citigroup

Amrize (NYSE:AMRZ) had its target price dropped by equities researchers at Citigroup from $58.00 to $50.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Citigroup’s target price would suggest a potential upside of 33.32% from the company’s current price.

A number of other equities research analysts have also recently issued reports on the stock. Stephens decreased their price objective on shares of Amrize from $65.00 to $54.00 and set an “overweight” rating for the company in a report on Wednesday, August 12th. DA Davidson initiated coverage on Amrize in a research note on Monday, August 24th. They set a “neutral” rating and a $50.00 price target for the company. Barclays started coverage on Amrize in a research note on Thursday. They issued an “equal weight” rating and a $55.00 price objective on the stock. JPMorgan Chase & Co. lowered Amrize from an “overweight” rating to a “neutral” rating and reduced their target price for the stock from $57.00 to $52.00 in a report on Wednesday, September 2nd. Finally, Bank of America reaffirmed an “underperform” rating and set a $40.00 target price (down from $50.00) on shares of Amrize in a research report on Wednesday, September 2nd. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, eight have given a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $52.76.

Amrize Trading Up 0.7%

Shares of AMRZ stock traded up $0.26 during trading hours on Friday, reaching $37.51. 2,168,691 shares of the stock traded hands, compared to its average volume of 3,373,587. The company has a quick ratio of 0.73, a current ratio of 1.10 and a debt-to-equity ratio of 0.33. Amrize has a 1-year low of $36.55 and a 1-year high of $65.94. The business has a fifty day moving average price of $43.88 and a 200 day moving average price of $50.20. The firm has a market capitalization of $20.74 billion, a PE ratio of 17.27, a PEG ratio of 1.31 and a beta of 0.21.

Amrize (NYSE:AMRZ) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The company had revenue of $3.49 billion for the quarter. On average, equities research analysts forecast that Amrize will post 2.46 EPS for the current year.

Insider Buying and Selling at Amrize

In related news, insider Jaime Hill bought 1,500 shares of Amrize stock in a transaction that occurred on Tuesday, August 11th. The stock was acquired at an average price of $47.12 per share, with a total value of $70,680.00. Following the acquisition, the insider owned 29,698 shares of the company’s stock, valued at approximately $1,399,369.76. This represents a 5.32% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Mario Gross purchased 3,568 shares of the company’s stock in a transaction that occurred on Tuesday, August 11th. The stock was bought at an average cost of $46.60 per share, with a total value of $166,268.80. Following the purchase, the insider owned 38,485 shares of the company’s stock, valued at $1,793,401. This represents a 10.22% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders have acquired 48,983 shares of company stock worth $2,158,755. 0.54% of the stock is currently owned by corporate insiders.

Institutional Trading of Amrize

A number of hedge funds have recently added to or reduced their stakes in AMRZ. Caldwell Sutter Capital Inc. increased its holdings in Amrize by 11.5% in the 1st quarter. Caldwell Sutter Capital Inc. now owns 2,675 shares of the company’s stock worth $150,000 after acquiring an additional 275 shares during the last quarter. Baldwin Investment Management LLC increased its position in shares of Amrize by 4.4% during the fourth quarter. Baldwin Investment Management LLC now owns 8,980 shares of the company’s stock valued at $486,000 after buying an additional 375 shares during the period. Mengis Capital Management Inc. boosted its position in shares of Amrize by 8.5% in the fourth quarter. Mengis Capital Management Inc. now owns 5,750 shares of the company’s stock valued at $311,000 after acquiring an additional 450 shares during the period. Norman Fields Gottscho Capital Management LLC grew its stake in Amrize by 4.3% during the second quarter. Norman Fields Gottscho Capital Management LLC now owns 11,515 shares of the company’s stock valued at $614,000 after acquiring an additional 475 shares in the last quarter. Finally, MCF Advisors LLC bought a new stake in Amrize during the 4th quarter worth approximately $27,000.

About Amrize

Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.

Amrize was established as the result of the separation of Holcim’s North American business and began operating as an independent, publicly traded company in 2025.